You are viewing an obsolete version of the DU website which is no longer supported by the Administrators. Visit The New DU.
Democratic Underground Latest Greatest Lobby Journals Search Options Help Login
Google

Reply #17: Keep the tinfoil hat on... Look at this - from one google search [View All]

Printer-friendly format Printer-friendly format
Printer-friendly format Email this thread to a friend
Printer-friendly format Bookmark this thread
This topic is archived.
Home » Discuss » Topic Forums » September 11 Donate to DU
eowyn_of_rohan Donating Member (1000+ posts) Send PM | Profile | Ignore Wed Apr-29-09 11:05 AM
Response to Reply #1
17. Keep the tinfoil hat on... Look at this - from one google search
Edited on Wed Apr-29-09 11:16 AM by eowyn_of_rohan
Baxter -One of five businesses honored as "Corporate Leaders" in Bush's EPA Performance Track program - RECENTLY SUSPENDED BY PRES. OBAMA. The Bush-era program allows companies who implement voluntary pollution controls to benefit from reduced environmental inspections and less stringent regulation. Companies complying with the program were in the so-called Green Club.

The Five "Corporate Leaders the now defunct EPA Performance Track program :
Baxter Healthcare Corporation
Johnson & Johnson
Rockwell Collins
Xanterra Parks and Resorts
Xerox Corporation

Baxter Healthcare 2005 Global EHS Conference, Chicago, IL 06/27/2005
KEYNOTE SPEAKER Bush-appointed EPA director MIKE LEAVITT -

"It is truly an honor for me to speak before you at Baxter Health Cares 2005 Global Environmental, Health and Safety Conference...
I was recently selected by President Bush to serve as the Administrator for EPA. It is an honor and a privilege to serve him and the people of this country.

EPA and Baxter are similar in the work we do to protect the health of the American people. You - by applying your expertise in medical devices, pharmaceuticals and biotechnology. And us - by controlling the pollutants released into our air, water and land.

I want to start by congratulating you on your recent designation as an EPA Performance Track Corporate Leader... Just being a member of this distinguished group is quite an accomplishment. But Baxter has been singled out from among those leaders as a Performance Track Corporate Leader one of only three companies that has been recognized for their commitment to environmental stewardship.

... EPA would like to collaborate with you to maximize the value you add beyond offering world-class health products...We will work with you through Performance Track to help more companies set and achieve environmental goals. We are committed to promoting your successes publicly and to setting up peer-to-peer exchanges that enable you to share proven practices with other Performance Track members.
~~~~~~~~~~
Long History of Research/Experimentation with PIGS

GENE-ALTERED PIGS PRODUCE KEY PART OF HUMAN BLOOD
By PHILIP J. HILTS
Published: Sunday, June 16, 1991
Using genetic engineering techniques, biologists have created pigs that produce human hemoglobin, the essential oxygen-carrying component of blood....

Experts said the achievement was a milestone in the effort to find a substitute for blood that could be used in all types of transfusions and might offer advantages over the donated blood now used. A blood substitute could be stored for months instead of weeks, would be free of any risk of human infection, and could be transfused into anyone without the need for blood typing and matching...

Dr. Timothy Estep, vice president for research at the Baxter Health Care Corporation, which has been working on extracting hemoglobin from human blood, said the DNX work was "an interesting milestone" in the development of hemoglobin through genetic engineering, adding: "It is one useful step among many that need to be taken to make a blood substitute. We believe that some product like this will be approved in the mid-1990's; things are moving fast."

Mr. Estep said the value of hemoglobin as a substitute for blood is generally accepted among experts. "Now the question that must be answered is, how safe are these products?" he said. (BACK WHEN THEY CARED)

Among the safety questions are whether some animal viruses might escape the purification process and cause illness in humans, and whether cellular debris missed in purification could cause kidney damage or allergic reactions.
~~~~~~~~~~~

Adelaide lab creates Australia's first cloned pig
PM Archive - Wednesday, 9 May , 2001
There are only three groups in the world that have produced cloned pigs and the applications of cloning are animal breeding perspective and also the possibility of using pig organs to meet the shortage of organs that are out there for donation. And our work is funded by one of the major players out there in that area and that's Baxter Health Care in the States, which is a billion dollar company. So basically they funded us to develop the cloning technology which will allow us to look at that research question in collaboration with our partners in Melbourne and whether we can use pigs as organ donors for humans.

~~~~~~~
HEPARIN PRODUCED BY BAXTER with contaminated, pig-derived ingredients from China
Monday, January 5, 2009
Heparin Debacle Tops Chicago Tribunes Top 10 Local Business Stories of 2008
On December 31, 2008, the Chicago Tribune reported on the top 10 local business stories of 2008. Heparin contaminated with oversulfated chondroitin sulfate (OSCS) that was manufactured and sold by Baxter Healthcare Corporation and Scientific Protein Laboratories, topped this list. (See 12/31/08 Chicago Tribune Article, Top 10 Local Business Stories of 2008.)
As more and more scientific literature continues to be published linking the contaminate to the hundreds of reported deaths and other adverse events, we expect and hope that this will remain an important public concern this year, particularly for those families who still are awaiting answers whether their loved ones were in fact victims of the tainted heparin.

~~~~~~~

Baxter named in class action over anti-coagulant Heparin

1/7/2009 2:00 PM
By Kelly Holleran

A class action suit against the maker of a blood thinning drug claims the company is substituting safer ingredients - cooked, dried pig intestines - with more dangerous ones. Joyce Ann Osteen of Illinois is suing Baxter over its anticoagulant drug Heparin in St. Clair County Circuit Court.

She claims the company began substituting a more dangerous ingredient to "reap greater profits as a result of utilizing cheap component parts."

.....Baxter began making the drug from enzymes found in pork intestines, according to the complaint filed Jan. 5. It takes about 3,500 pigs' intestines to produce 2.2 pounds of raw Heparin, the suit states. Once intestines are gathered from slaughtered pigs, intestines are cooked. After the intestines are dry, a granular substance called crude Heparin emerges, according to the complaint.

"The crude Heparin is then processed to remove impurities and results in the production of an API such as Heparin Sodium or Heparin Lithium," the suit states. "This processing may include, but is not limited to, fractional precipitation, purification and chemical treatment."

On March 5, Baxter found a much cheaper way to produce the drug, the suit claims. The company discovered a molecule similar to Heparin in Heparin Sodium, according to the complaint. "On or about March 19, 2008, and prior thereto, the heparin-like molecule contaminant in Heparin products was identified as over-sulfated chondroitin sulfate (hereinafter "OSCS")," the suit states.

OSCS mimics Heparin's activities, and Baxter began to use it to dilute or to substitute for the active pharmaceutical ingredient in Heparin, according to the complaint.

OSCS costs only $9 to produce compared to the $900 it takes to produce heparin, the suit states.

However, OSCS is not found in nature and is not approved in the United States, Osteen alleges.

"Un-approved API's significantly increases the likelihood that exposed patients will experience adverse side effects and reactions that can result from the un-approved doses," the suit states. "In other words, an unapproved API enhances the risk and danger."

...The FDA made an announcement on March 19 that the mysterious contaminant in Heparin was an inexpensive, unapproved ingredient altered to mimic the real ingredient, Osteen claims.

As of April 8, there have been 103 reported deaths in patients who received Heparin since Jan. 1, 2007, the suit states. Of those deaths, 91 were reported after Jan. 1, 2008, the suit states.

"On or about July 30, 2008, the FDA conclusively linked the deaths of patients infused with Heparin to specific lots made by Baxter," the suit states. "The specific lots of Baxter product tested positive for OSCS."

..."The Recalled Heparin was adulterated, misbranded, defective, unreasonably dangerous and unfit for its intended uses," the suit states. "Baxter placed tens of thousands of patients, including the Plaintiff at unnecessarily risk of serious injury and/or death."

Baxter engaged in unfair and deceptive acts and violated the Illinois Consumer Fraud and Deceptive Business Practices Act by knowingly concealing its own data from investigations about the true efficacy of Heparin, Osteen alleges.

It also violated the ICFA by knowingly suppressing its own data from investigations on the safety of Heparin, by intentionally concealing the true health hazards of Heparin and by recklessly omitting that use of Heparin poses a significant increased risk of sepsis and other serious infections, according to the complaint.

Baxter omitted the true health risks of Heparin from Osteen's prescribing physicians with the intent that the omissions convince her to purchase the drug, the suit states.


"Plaintiff and the Class members who purchased Heparin suffered actual damages as a proximate result of Baxter Healthcare Corp.'s deception in that they were deprived of the benefit of their bargain," the suit states.

Printer Friendly | Permalink |  | Top
 

Home » Discuss » Topic Forums » September 11 Donate to DU

Powered by DCForum+ Version 1.1 Copyright 1997-2002 DCScripts.com
Software has been extensively modified by the DU administrators


Important Notices: By participating on this discussion board, visitors agree to abide by the rules outlined on our Rules page. Messages posted on the Democratic Underground Discussion Forums are the opinions of the individuals who post them, and do not necessarily represent the opinions of Democratic Underground, LLC.

Home  |  Discussion Forums  |  Journals |  Store  |  Donate

About DU  |  Contact Us  |  Privacy Policy

Got a message for Democratic Underground? Click here to send us a message.

© 2001 - 2011 Democratic Underground, LLC